Structure

Physi-Chem Properties

Molecular Weight:  840.26
Volume:  786.444
LogP:  3.016
LogD:  1.04
LogS:  -4.617
# Rotatable Bonds:  10
TPSA:  326.88
# H-Bond Aceptor:  20
# H-Bond Donor:  13
# Rings:  7
# Heavy Atoms:  20

MedChem Properties

QED Drug-Likeness Score:  0.056
Synthetic Accessibility Score:  5.615
Fsp3:  0.4
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.768
MDCK Permeability:  4.748897936224239e-06
Pgp-inhibitor:  0.214
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.99
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.004
Plasma Protein Binding (PPB):  79.71375274658203%
Volume Distribution (VD):  0.776
Pgp-substrate:  50.18973922729492%

ADMET: Metabolism

CYP1A2-inhibitor:  0.047
CYP1A2-substrate:  0.139
CYP2C19-inhibitor:  0.024
CYP2C19-substrate:  0.046
CYP2C9-inhibitor:  0.059
CYP2C9-substrate:  0.066
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.106
CYP3A4-inhibitor:  0.003
CYP3A4-substrate:  0.001

ADMET: Excretion

Clearance (CL):  0.71
Half-life (T1/2):  0.635

ADMET: Toxicity

hERG Blockers:  0.019
Human Hepatotoxicity (H-HT):  0.316
Drug-inuced Liver Injury (DILI):  0.988
AMES Toxicity:  0.303
Rat Oral Acute Toxicity:  0.004
Maximum Recommended Daily Dose:  0.128
Skin Sensitization:  0.927
Carcinogencity:  0.027
Eye Corrosion:  0.003
Eye Irritation:  0.018
Respiratory Toxicity:  0.059

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC252156

Natural Product ID:  NPC252156
Common Name*:   Pradimicin A
IUPAC Name:   (2R)-2-[[(5S,6S)-1,6,9,14-tetrahydroxy-5-[(2S,3R,4S,5S,6R)-3-hydroxy-6-methyl-5-(methylamino)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-11-methoxy-3-methyl-8,13-dioxo-5,6-dihydrobenzo[a]tetracene-2-carbonyl]amino]propanoic acid
Synonyms:   Pradimicin A; Pradimicin-A
Standard InCHIKey:  WPICPWIIIBCXCV-NJGWPHBESA-N
Standard InCHI:  InChI=1S/C40H44N2O18/c1-11-6-18-24(31(49)21(11)37(53)42-12(2)38(54)55)23-16(9-17-25(32(23)50)28(46)15-7-14(56-5)8-19(43)22(15)27(17)45)29(47)35(18)59-40-34(52)36(26(41-4)13(3)58-40)60-39-33(51)30(48)20(44)10-57-39/h6-9,12-13,20,26,29-30,33-36,39-41,43-44,47-52H,10H2,1-5H3,(H,42,53)(H,54,55)/t12-,13-,20-,26+,29+,30+,33-,34-,35+,36+,39+,40+/m1/s1
SMILES:  CN[C@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1O[C@@H]1OC[C@H]([C@@H]([C@H]1O)O)O)O)O[C@@H]1[C@@H](O)c2cc3c(c(c2c2c1cc(C)c(c2O)C(=N[C@@H](C(=O)O)C)O)O)C(=O)c1c(C3=O)c(O)cc(c1)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1673205
PubChem CID:   5479145
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000022] Naphthacenes
        • [CHEMONTID:0000155] Tetracenequinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21079 Actinomadura hibisca Species Thermomonosporaceae Bacteria n.a. n.a. n.a. DOI[10.1021/jo00272a013]
NPO21079 Actinomadura hibisca Species Thermomonosporaceae Bacteria n.a. n.a. n.a. PMID[21119678]
NPO21079 Actinomadura hibisca Species Thermomonosporaceae Bacteria n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT927 Cell Line PBMC Homo sapiens Activity > 95.0 % PMID[458335]
NPT927 Cell Line PBMC Homo sapiens CC50 > 50000.0 nM PMID[458335]
NPT492 Cell Line Caco-2 Homo sapiens CC50 > 50000.0 nM PMID[458335]
NPT3552 Cell Line OST Homo sapiens CC50 > 50000.0 nM PMID[458335]
NPT165 Cell Line HeLa Homo sapiens CC50 > 50000.0 nM PMID[458335]
NPT112 Cell Line MOLT-4 Homo sapiens CC50 > 50000.0 nM PMID[458335]
NPT1452 Cell Line C8166 Homo sapiens CC50 > 50000.0 nM PMID[458335]
NPT137 Cell Line L1210 Mus musculus CC50 > 50000.0 nM PMID[458335]
NPT927 Cell Line PBMC Homo sapiens CC50 > 250000.0 nM PMID[458335]
NPT25 Cell Line MT4 Homo sapiens CC50 > 50000.0 nM PMID[458335]
NPT404 Cell Line CCRF-CEM Homo sapiens CC50 > 100000.0 nM PMID[458335]
NPT927 Cell Line PBMC Homo sapiens FC = 4.0 n.a. PMID[458335]
NPT927 Cell Line PBMC Homo sapiens FC = 2.0 n.a. PMID[458335]
NPT404 Cell Line CCRF-CEM Homo sapiens EC50 > 50000.0 nM PMID[458336]
NPT333 Cell Line CEM Homo sapiens CC50 > 100000.0 nM PMID[458338]
NPT333 Cell Line CEM Homo sapiens CC50 > 100000.0 nM PMID[458340]
NPT333 Cell Line CEM Homo sapiens CC50 > 50000.0 nM PMID[458341]
NPT25 Cell Line MT4 Homo sapiens CC50 > 100000.0 nM PMID[458342]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 > 50000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 5200.0 nM PMID[458335]
NPT2 Others Unspecified Kd = 14900.0 nM PMID[458335]
NPT2 Others Unspecified Kd = 410.0 nM PMID[458335]
NPT2 Others Unspecified Kd = 2.91 10'-2/s PMID[458335]
NPT2 Others Unspecified Ka = 1.96 10'3/M/s PMID[458335]
NPT2 Others Unspecified Kd = 6.1 10'-3/s PMID[458335]
NPT2 Others Unspecified Ka = 1.49 10'4/M/s PMID[458335]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 16000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 3400.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 5400.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 IC50 = 21000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 IC50 = 3500.0 nM PMID[458335]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. EC50 = 4300.0 nM PMID[458335]
NPT27 Others Unspecified CC50 > 50000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 Ratio = 2.0 n.a. PMID[458335]
NPT3795 Organism Human immunodeficiency virus 2 Human immunodeficiency virus 2 EC50 = 4300.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 2200.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 2600.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 1600.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 6700.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 8000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 4700.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 3000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 10000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 6000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 5900.0 nM PMID[458335]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. EC50 = 5500.0 nM PMID[458335]
NPT332 Organism Human immunodeficiency virus type 2 (ISOLATE ROD) Human immunodeficiency virus type 2 (ISOLATE ROD) EC50 = 5000.0 nM PMID[458335]
NPT332 Organism Human immunodeficiency virus type 2 (ISOLATE ROD) Human immunodeficiency virus type 2 (ISOLATE ROD) EC50 = 5200.0 nM PMID[458335]
NPT35 Others n.a. Activity = 50.0 uM PMID[458335]
NPT35 Others n.a. Solubility > 20000.0 nM PMID[458335]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 5200.0 nM PMID[458336]
NPT332 Organism Human immunodeficiency virus type 2 (ISOLATE ROD) Human immunodeficiency virus type 2 (ISOLATE ROD) EC50 = 5900.0 nM PMID[458336]
NPT35 Others n.a. Solubility = 20.0 ug.mL-1 PMID[458337]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 3300.0 nM PMID[458338]
NPT332 Organism Human immunodeficiency virus type 2 (ISOLATE ROD) Human immunodeficiency virus type 2 (ISOLATE ROD) EC50 = 5900.0 nM PMID[458338]
NPT2 Others Unspecified Activity = 0.57 molar ratio PMID[458339]
NPT2 Others Unspecified Activity = 1.08 molar ratio PMID[458339]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 3300.0 nM PMID[458340]
NPT332 Organism Human immunodeficiency virus type 2 (ISOLATE ROD) Human immunodeficiency virus type 2 (ISOLATE ROD) EC50 = 5900.0 nM PMID[458340]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 3400.0 nM PMID[458341]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 3300.0 nM PMID[458342]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 5900.0 nM PMID[458342]
NPT2 Others Unspecified Ratio CC50/EC50 > 30.3 n.a. PMID[458342]
NPT20 Organism Candida albicans Candida albicans PD50 = 8.9 mg kg-1 PMID[458343]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC252156 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8473 Intermediate Similarity NPC313274
0.8465 Intermediate Similarity NPC315351
0.8465 Intermediate Similarity NPC316412
0.8429 Intermediate Similarity NPC315253
0.8398 Intermediate Similarity NPC314941
0.8382 Intermediate Similarity NPC261012
0.8382 Intermediate Similarity NPC314738
0.8382 Intermediate Similarity NPC109403
0.8365 Intermediate Similarity NPC315889
0.8333 Intermediate Similarity NPC42286
0.8259 Intermediate Similarity NPC87583
0.8182 Intermediate Similarity NPC314946
0.8168 Intermediate Similarity NPC221140
0.8168 Intermediate Similarity NPC475352
0.8168 Intermediate Similarity NPC229817
0.8168 Intermediate Similarity NPC473686
0.8168 Intermediate Similarity NPC475220
0.8109 Intermediate Similarity NPC477860
0.8109 Intermediate Similarity NPC475161
0.8098 Intermediate Similarity NPC264302
0.8069 Intermediate Similarity NPC473631
0.8069 Intermediate Similarity NPC475662
0.8069 Intermediate Similarity NPC473717
0.8069 Intermediate Similarity NPC293227
0.806 Intermediate Similarity NPC277710
0.806 Intermediate Similarity NPC299149
0.806 Intermediate Similarity NPC153578
0.806 Intermediate Similarity NPC114257
0.805 Intermediate Similarity NPC46958
0.8039 Intermediate Similarity NPC105591
0.8 Intermediate Similarity NPC68381
0.799 Intermediate Similarity NPC316164
0.798 Intermediate Similarity NPC313452
0.796 Intermediate Similarity NPC475246
0.7951 Intermediate Similarity NPC65489
0.795 Intermediate Similarity NPC472054
0.7936 Intermediate Similarity NPC313582
0.7931 Intermediate Similarity NPC315221
0.7931 Intermediate Similarity NPC470452
0.7931 Intermediate Similarity NPC470448
0.7931 Intermediate Similarity NPC164047
0.7931 Intermediate Similarity NPC470453
0.791 Intermediate Similarity NPC3718
0.791 Intermediate Similarity NPC63105
0.79 Intermediate Similarity NPC111536
0.79 Intermediate Similarity NPC5029
0.79 Intermediate Similarity NPC271385
0.79 Intermediate Similarity NPC30432
0.79 Intermediate Similarity NPC76128
0.7892 Intermediate Similarity NPC329790
0.7882 Intermediate Similarity NPC84494
0.7882 Intermediate Similarity NPC245059
0.7874 Intermediate Similarity NPC31208
0.7874 Intermediate Similarity NPC472721
0.7874 Intermediate Similarity NPC472724
0.7874 Intermediate Similarity NPC160543
0.7874 Intermediate Similarity NPC93065
0.7874 Intermediate Similarity NPC469652
0.7874 Intermediate Similarity NPC314672
0.7874 Intermediate Similarity NPC472720
0.7871 Intermediate Similarity NPC289876
0.7867 Intermediate Similarity NPC174140
0.7861 Intermediate Similarity NPC85368
0.7861 Intermediate Similarity NPC213052
0.7861 Intermediate Similarity NPC203751
0.7854 Intermediate Similarity NPC231254
0.785 Intermediate Similarity NPC298778
0.7843 Intermediate Similarity NPC85316
0.7843 Intermediate Similarity NPC197357
0.783 Intermediate Similarity NPC319774
0.7826 Intermediate Similarity NPC240200
0.7826 Intermediate Similarity NPC290289
0.7826 Intermediate Similarity NPC158214
0.7826 Intermediate Similarity NPC223534
0.7821 Intermediate Similarity NPC314743
0.7816 Intermediate Similarity NPC241847
0.7811 Intermediate Similarity NPC477836
0.781 Intermediate Similarity NPC316274
0.781 Intermediate Similarity NPC470196
0.781 Intermediate Similarity NPC470198
0.781 Intermediate Similarity NPC470195
0.781 Intermediate Similarity NPC470193
0.781 Intermediate Similarity NPC470194
0.781 Intermediate Similarity NPC282474
0.781 Intermediate Similarity NPC470197
0.781 Intermediate Similarity NPC470200
0.7804 Intermediate Similarity NPC314596
0.7794 Intermediate Similarity NPC58538
0.7794 Intermediate Similarity NPC212290
0.7789 Intermediate Similarity NPC477835
0.7788 Intermediate Similarity NPC187632
0.7783 Intermediate Similarity NPC472723
0.7783 Intermediate Similarity NPC76112
0.7783 Intermediate Similarity NPC475233
0.7783 Intermediate Similarity NPC92403
0.7783 Intermediate Similarity NPC170018
0.7783 Intermediate Similarity NPC102053
0.7783 Intermediate Similarity NPC66820
0.7783 Intermediate Similarity NPC170101
0.7778 Intermediate Similarity NPC260521
0.7778 Intermediate Similarity NPC469649
0.7767 Intermediate Similarity NPC292706
0.7767 Intermediate Similarity NPC224557
0.7762 Intermediate Similarity NPC477082
0.7751 Intermediate Similarity NPC40078
0.7751 Intermediate Similarity NPC471091
0.7751 Intermediate Similarity NPC48474
0.7751 Intermediate Similarity NPC97924
0.774 Intermediate Similarity NPC205721
0.7734 Intermediate Similarity NPC477992
0.7734 Intermediate Similarity NPC474345
0.7734 Intermediate Similarity NPC146803
0.7734 Intermediate Similarity NPC199533
0.7734 Intermediate Similarity NPC470454
0.7734 Intermediate Similarity NPC477991
0.7729 Intermediate Similarity NPC469650
0.7729 Intermediate Similarity NPC261623
0.7729 Intermediate Similarity NPC111490
0.7714 Intermediate Similarity NPC314459
0.7714 Intermediate Similarity NPC470199
0.7711 Intermediate Similarity NPC259905
0.7711 Intermediate Similarity NPC222455
0.77 Intermediate Similarity NPC178851
0.7696 Intermediate Similarity NPC477816
0.7689 Intermediate Similarity NPC3474
0.7689 Intermediate Similarity NPC108487
0.7685 Intermediate Similarity NPC98776
0.7685 Intermediate Similarity NPC470336
0.7685 Intermediate Similarity NPC470335
0.7681 Intermediate Similarity NPC75574
0.7673 Intermediate Similarity NPC76047
0.767 Intermediate Similarity NPC208069
0.7662 Intermediate Similarity NPC472058
0.7662 Intermediate Similarity NPC234497
0.7662 Intermediate Similarity NPC470341
0.7662 Intermediate Similarity NPC324522
0.7662 Intermediate Similarity NPC105414
0.7662 Intermediate Similarity NPC249977
0.7659 Intermediate Similarity NPC267549
0.7659 Intermediate Similarity NPC470334
0.7656 Intermediate Similarity NPC477083
0.7656 Intermediate Similarity NPC473618
0.7656 Intermediate Similarity NPC477081
0.7656 Intermediate Similarity NPC269046
0.765 Intermediate Similarity NPC478022
0.765 Intermediate Similarity NPC478020
0.7647 Intermediate Similarity NPC321226
0.7647 Intermediate Similarity NPC478046
0.7647 Intermediate Similarity NPC470667
0.7647 Intermediate Similarity NPC180210
0.7647 Intermediate Similarity NPC314914
0.7647 Intermediate Similarity NPC328856
0.7647 Intermediate Similarity NPC478047
0.7647 Intermediate Similarity NPC186800
0.7644 Intermediate Similarity NPC112380
0.7642 Intermediate Similarity NPC313453
0.7633 Intermediate Similarity NPC129533
0.7633 Intermediate Similarity NPC132111
0.7633 Intermediate Similarity NPC123259
0.763 Intermediate Similarity NPC204580
0.7621 Intermediate Similarity NPC80956
0.7621 Intermediate Similarity NPC472726
0.7621 Intermediate Similarity NPC472725
0.7619 Intermediate Similarity NPC201814
0.7617 Intermediate Similarity NPC131405
0.7613 Intermediate Similarity NPC316368
0.7613 Intermediate Similarity NPC284236
0.761 Intermediate Similarity NPC67629
0.761 Intermediate Similarity NPC297574
0.761 Intermediate Similarity NPC79736
0.7608 Intermediate Similarity NPC179947
0.7608 Intermediate Similarity NPC237202
0.7606 Intermediate Similarity NPC133775
0.7602 Intermediate Similarity NPC478048
0.7598 Intermediate Similarity NPC25724
0.7598 Intermediate Similarity NPC168789
0.7598 Intermediate Similarity NPC199357
0.7596 Intermediate Similarity NPC49690
0.7596 Intermediate Similarity NPC318119
0.7594 Intermediate Similarity NPC476358
0.7594 Intermediate Similarity NPC83019
0.7586 Intermediate Similarity NPC470272
0.7585 Intermediate Similarity NPC208797
0.7585 Intermediate Similarity NPC53680
0.7585 Intermediate Similarity NPC8940
0.7585 Intermediate Similarity NPC469371
0.7574 Intermediate Similarity NPC470271
0.7574 Intermediate Similarity NPC190204
0.7574 Intermediate Similarity NPC43918
0.7574 Intermediate Similarity NPC311389
0.7574 Intermediate Similarity NPC261411
0.7573 Intermediate Similarity NPC472387
0.7571 Intermediate Similarity NPC173872
0.7571 Intermediate Similarity NPC7839
0.7571 Intermediate Similarity NPC119094
0.7571 Intermediate Similarity NPC142291
0.7569 Intermediate Similarity NPC46990
0.7562 Intermediate Similarity NPC178281
0.7562 Intermediate Similarity NPC7752
0.7559 Intermediate Similarity NPC314687

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC252156 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9343 High Similarity NPD8151 Discontinued
0.8689 High Similarity NPD7801 Approved
0.8585 High Similarity NPD8155 Clinical (unspecified phase)
0.8578 High Similarity NPD7871 Phase 2
0.8578 High Similarity NPD7870 Phase 2
0.8571 High Similarity NPD6823 Phase 2
0.8529 High Similarity NPD7698 Approved
0.8529 High Similarity NPD7696 Phase 3
0.8529 High Similarity NPD7697 Approved
0.851 High Similarity NPD7783 Phase 2
0.851 High Similarity NPD7782 Clinical (unspecified phase)
0.8454 Intermediate Similarity NPD7701 Phase 2
0.8398 Intermediate Similarity NPD8320 Phase 1
0.8398 Intermediate Similarity NPD8319 Approved
0.8382 Intermediate Similarity NPD6780 Approved
0.8382 Intermediate Similarity NPD6781 Approved
0.8382 Intermediate Similarity NPD6779 Approved
0.8382 Intermediate Similarity NPD6782 Approved
0.8382 Intermediate Similarity NPD6778 Approved
0.8382 Intermediate Similarity NPD6777 Approved
0.8382 Intermediate Similarity NPD6776 Approved
0.8373 Intermediate Similarity NPD7874 Approved
0.8373 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD7699 Phase 2
0.8284 Intermediate Similarity NPD7700 Phase 2
0.8219 Intermediate Similarity NPD8059 Phase 3
0.8219 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.8173 Intermediate Similarity NPD7435 Discontinued
0.8137 Intermediate Similarity NPD6535 Approved
0.8137 Intermediate Similarity NPD6534 Approved
0.8047 Intermediate Similarity NPD7930 Approved
0.784 Intermediate Similarity NPD7999 Approved
0.781 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7783 Intermediate Similarity NPD8313 Approved
0.7783 Intermediate Similarity NPD8312 Approved
0.7778 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.767 Intermediate Similarity NPD8150 Discontinued
0.7656 Intermediate Similarity NPD6212 Phase 3
0.7656 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7656 Intermediate Similarity NPD6213 Phase 3
0.7593 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD6973 Clinical (unspecified phase)
0.7512 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7477 Intermediate Similarity NPD7584 Approved
0.7456 Intermediate Similarity NPD8491 Approved
0.7443 Intermediate Similarity NPD7585 Approved
0.7438 Intermediate Similarity NPD7473 Discontinued
0.7434 Intermediate Similarity NPD8366 Approved
0.7413 Intermediate Similarity NPD6959 Discontinued
0.7397 Intermediate Similarity NPD7583 Approved
0.7387 Intermediate Similarity NPD7827 Phase 1
0.7376 Intermediate Similarity NPD6232 Discontinued
0.7366 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD8469 Approved
0.7343 Intermediate Similarity NPD6559 Discontinued
0.733 Intermediate Similarity NPD7074 Phase 3
0.733 Intermediate Similarity NPD7472 Approved
0.7315 Intermediate Similarity NPD7565 Approved
0.7315 Intermediate Similarity NPD8285 Discontinued
0.7308 Intermediate Similarity NPD7808 Phase 3
0.7303 Intermediate Similarity NPD8152 Approved
0.7303 Intermediate Similarity NPD8153 Approved
0.7291 Intermediate Similarity NPD5710 Approved
0.7291 Intermediate Similarity NPD5711 Approved
0.7282 Intermediate Similarity NPD7054 Approved
0.726 Intermediate Similarity NPD7251 Discontinued
0.7212 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD6797 Phase 2
0.7202 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD5844 Phase 1
0.7178 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.715 Intermediate Similarity NPD7228 Approved
0.7136 Intermediate Similarity NPD5006 Approved
0.7136 Intermediate Similarity NPD5005 Approved
0.7123 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7114 Intermediate Similarity NPD7819 Suspended
0.7067 Intermediate Similarity NPD3818 Discontinued
0.7064 Intermediate Similarity NPD7282 Approved
0.7062 Intermediate Similarity NPD5026 Approved
0.7062 Intermediate Similarity NPD5034 Approved
0.7062 Intermediate Similarity NPD4954 Approved
0.7062 Intermediate Similarity NPD5028 Approved
0.7062 Intermediate Similarity NPD36 Approved
0.7062 Intermediate Similarity NPD4955 Approved
0.7062 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD8163 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD8162 Phase 2
0.7053 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD6166 Phase 2
0.7053 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.705 Intermediate Similarity NPD4380 Phase 2
0.7044 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD8067 Phase 3
0.7031 Intermediate Similarity NPD8404 Phase 2
0.703 Intermediate Similarity NPD8455 Phase 2
0.7024 Intermediate Similarity NPD6746 Phase 2
0.7021 Intermediate Similarity NPD7654 Discontinued
0.7014 Intermediate Similarity NPD5030 Phase 2
0.7014 Intermediate Similarity NPD7038 Approved
0.7014 Intermediate Similarity NPD7039 Approved
0.701 Intermediate Similarity NPD7075 Discontinued
0.7009 Intermediate Similarity NPD5037 Approved
0.7009 Intermediate Similarity NPD5038 Approved
0.6996 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6986 Remote Similarity NPD8485 Approved
0.6981 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6963 Remote Similarity NPD5036 Approved
0.6955 Remote Similarity NPD4420 Approved
0.6948 Remote Similarity NPD5035 Approved
0.6934 Remote Similarity NPD7240 Approved
0.692 Remote Similarity NPD8461 Discontinued
0.6916 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6912 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6905 Remote Similarity NPD7177 Discontinued
0.6878 Remote Similarity NPD7768 Phase 2
0.6866 Remote Similarity NPD8360 Approved
0.6866 Remote Similarity NPD8361 Approved
0.6863 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6863 Remote Similarity NPD7096 Clinical (unspecified phase)
0.686 Remote Similarity NPD4666 Phase 3
0.6854 Remote Similarity NPD8368 Discontinued
0.6847 Remote Similarity NPD7411 Suspended
0.684 Remote Similarity NPD8492 Approved
0.6837 Remote Similarity NPD8407 Phase 2
0.6834 Remote Similarity NPD7390 Discontinued
0.6832 Remote Similarity NPD7458 Discontinued
0.6829 Remote Similarity NPD5353 Approved
0.6825 Remote Similarity NPD3751 Discontinued
0.6825 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6818 Remote Similarity NPD4360 Phase 2
0.6818 Remote Similarity NPD4363 Phase 3
0.6815 Remote Similarity NPD8367 Approved
0.6814 Remote Similarity NPD37 Approved
0.6812 Remote Similarity NPD6234 Discontinued
0.6812 Remote Similarity NPD5709 Phase 3
0.6806 Remote Similarity NPD8055 Clinical (unspecified phase)
0.68 Remote Similarity NPD2532 Approved
0.68 Remote Similarity NPD2534 Approved
0.68 Remote Similarity NPD2533 Approved
0.6796 Remote Similarity NPD4967 Phase 2
0.6796 Remote Similarity NPD4965 Approved
0.6796 Remote Similarity NPD4966 Approved
0.6792 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6789 Remote Similarity NPD8435 Approved
0.678 Remote Similarity NPD1465 Phase 2
0.6776 Remote Similarity NPD5027 Approved
0.6776 Remote Similarity NPD5031 Approved
0.6776 Remote Similarity NPD5029 Approved
0.6771 Remote Similarity NPD7810 Phase 3
0.6771 Remote Similarity NPD7811 Phase 3
0.6766 Remote Similarity NPD7907 Approved
0.6762 Remote Similarity NPD5242 Approved
0.6749 Remote Similarity NPD2649 Approved
0.6749 Remote Similarity NPD2651 Approved
0.6732 Remote Similarity NPD1934 Approved
0.6732 Remote Similarity NPD6801 Discontinued
0.673 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6729 Remote Similarity NPD3823 Discontinued
0.6726 Remote Similarity NPD7497 Discontinued
0.6714 Remote Similarity NPD3787 Discontinued
0.6699 Remote Similarity NPD5494 Approved
0.6697 Remote Similarity NPD3863 Clinical (unspecified phase)
0.6683 Remote Similarity NPD3749 Approved
0.6683 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6683 Remote Similarity NPD6677 Suspended
0.6681 Remote Similarity NPD6863 Phase 2
0.6667 Remote Similarity NPD6841 Approved
0.6667 Remote Similarity NPD3226 Approved
0.6667 Remote Similarity NPD7693 Approved
0.6667 Remote Similarity NPD6843 Phase 3
0.6667 Remote Similarity NPD6842 Approved
0.6652 Remote Similarity NPD5968 Phase 3
0.6637 Remote Similarity NPD7667 Clinical (unspecified phase)
0.6637 Remote Similarity NPD4361 Phase 2
0.6637 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6634 Remote Similarity NPD4661 Approved
0.6634 Remote Similarity NPD4662 Approved
0.6626 Remote Similarity NPD6625 Approved
0.6626 Remote Similarity NPD7922 Phase 1
0.6621 Remote Similarity NPD8424 Clinical (unspecified phase)
0.662 Remote Similarity NPD7685 Pre-registration
0.661 Remote Similarity NPD4111 Phase 1
0.661 Remote Similarity NPD4665 Approved
0.6603 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6602 Remote Similarity NPD6386 Approved
0.6602 Remote Similarity NPD6385 Approved
0.6602 Remote Similarity NPD7708 Approved
0.6593 Remote Similarity NPD4914 Approved
0.659 Remote Similarity NPD5032 Approved
0.6589 Remote Similarity NPD2163 Approved
0.6589 Remote Similarity NPD6620 Discovery
0.6588 Remote Similarity NPD7199 Phase 2
0.6587 Remote Similarity NPD5402 Approved
0.6587 Remote Similarity NPD3817 Phase 2
0.6579 Remote Similarity NPD7680 Approved
0.6573 Remote Similarity NPD7997 Clinical (unspecified phase)
0.6573 Remote Similarity NPD3451 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data